arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

IRADIMED CORP

IRMD
$92.37 ▲ +1.15 (+1.26%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
55 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
82
Health
Excellent
Bullish
auto_awesome

Analytical Summary

IRADIMED CORP shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.2B
Dividend Yield
Revenue Growth 0.3%
Op. Margin 31.2%
ROIC 4.8%
FCF / Share $0.45
Trailing P/E 225.3x
Price / Book 11.6x
FCF Yield 0.5%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

55-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$20.47M
— +0.3%
Net Income Profit after all expenses
$5.82M
↑ +24.1%
Operating Margin Operating profit as % of sales
31.2%
↓ -5.2% 87th
FCF / Share Free cash flow per share
$0.45
↓ -27.0%
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
86
Returns
90
Cash Quality
51

Dividend History

Dividend / share · sourced from SEC filings
$0.48 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 55 quarters